Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
(This story was generated using AI and automation, please see disclaimer ) Overview US healthcare conglomerate's Q3 sales rose 5.9%, slightly beating analyst expectations Adjusted EPS for Q3 was $2.59, beating analyst expectations Company raised 2026 sales and adjusted EPS guidance Outlook Johnson & Johnson raises 2026
Revenue: $112.69B (est $111.03B) - Adjusted EPS: $4.69 (est $4.12) - EPS: $4.56 vs $2.59 Y/Y - UnitedHealthcare Segment Revenue: $86.33B (est $84.87B) - Optum Revenue: $66.88B (est $66.48B) - Total Enrollments: 48.30M (est 48.62M) - Medical Care Ratio: 88.4% (est 89.9%) - Operating Cost Ratio: 12.8% (est 12.6%) - Opera
Earnings season kicks off this week as several of the largest financial companies report quarterly financial results. The week is a big one for the Dow Jones Industrial Average, with five of its 30 components reporting. Dow Jones Industrial Average Gets Spotlight To kick off earnings season, the Dow Jones Industrial Av
UnitedHealth is scheduled to report Q3'26 results October 13 before the market opens. Revenue and EPS estimates are provided in the source.
UnitedHealth Group (UNH) is scheduled to report its Q3'26 earnings on October 13, prior to the market open. The consensus revenue estimate for the quarter is 111.31 billion USD, with an anticipated EPS of 4.12 USD.
Earnings are in focus on Thursday, with a -selected slate that runs from industrial engines and logistics real estate to streaming and medical devices. With guidance and segment commentary often moving stocks as much as the headline numbers, the options market offers a real-time snapshot of how much volatility traders